- 全部删除
 
您的购物车当前为空
Aβ42-IN-1 free base是一种口服活性的γ-secretase调节剂,具有高暴露度。该化合物能显著降低小鼠脑中Aβ42的水平,IC50为0.091 μM,显示出在阿尔茨海默病研究中的潜力。

Aβ42-IN-1 free base是一种口服活性的γ-secretase调节剂,具有高暴露度。该化合物能显著降低小鼠脑中Aβ42的水平,IC50为0.091 μM,显示出在阿尔茨海默病研究中的潜力。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 25 mg | ¥ 10,600  | 6-8周 | |
| 50 mg | ¥ 13,800  | 6-8周 | |
| 100 mg | ¥ 17,500  | 6-8周 | 
Aβ42-IN-1 free base 相关产品
| 产品描述 | Aβ42-IN-1 free base (compound 1v), an orally active γ-secretase modulator with high brain exposure, effectively lowers Aβ42 levels, exhibiting an IC 50 of 0.091 μM, and significantly diminishes brain Aβ42 levels in mice. Given these properties, Aβ42-IN-1 free base represents a potential disease-modifying agent for Alzheimer’s disease [1].  | 
| 体内活性 | Aβ42-IN-1 free base treatment exhibits that the CL int value is 84.7 μL/min/mg protein [1]. Animal Model: Nonfasted 8-week-old male ddY mice [1] Dosage: 30 mg/kg Administration: p.o. (Pharmacokinetic Analysis) Result: The CL int is 84.7 μL/min/mg protein.  | 
| 分子量 | 462.54 | 
| 分子式 | C29H26N4O2 | 
| CAS No. | 2434633-17-5 | 
| 密度 | 1.20 g/cm3 (Predicted) | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容